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mRNA expression analysis of the SUMO pathway genes in the
adult mouse retina
Vı´ctor Abad-Morales1, Elena B. Dome`nech1, Alejandro Garanto1,* and Gemma Marfany1,2,3,`
ABSTRACT
Sumoylation is a reversible post-translational modification that
regulates different cellular processes by conjugation/deconjugation
of SUMO moieties to target proteins. Most work on the functional
relevance of SUMOhas focused on cell cycle, DNA repair and cancer
in cultured cells, but data on the inter-dependence of separate
components of the SUMO pathway in highly specialized tissues,
such as the retina, is still scanty. Nonetheless, several retinal
transcription factors (TFs) relevant for cone and rod fate, as well as
some circadian rhythm regulators, are regulated by sumoylation.
Here we present a comprehensive survey of SUMO pathway gene
expression in the murine retina by quantitative RT-PCR and in situ
hybridization (ISH). The mRNA expression levels were quantified in
retinas obtained under four different light/dark conditions, revealing
distinct levels of gene expression. In addition, a SUMO pathway
retinal gene atlas based on themRNA expression pattern was drawn.
Although most genes are ubiquitously expressed, some patterns
could be defined in a first step to determine its biological significance
and interdependence. The wide expression of the SUMO pathway
genes, the transcriptional response under several light/dark
conditions, and the diversity of expression patterns in different cell
layers clearly support sumoylation as a relevant post-translational
modification in the retina. This expression atlas intends to be a
reference framework for retinal researchers and to depict a more
comprehensive view of the SUMO-regulated processes in the retina.
KEY WORDS: SUMO, sumoylation, In situ hybridization,
mRNA expression levels, retina, light cycle
INTRODUCTION
Sumoylation, the covalent conjugation of a small ubiquitin-like
modifier (SUMO) to a target protein, is a cell signalling
mechanism involved in the regulation of essential cellular and
developmental processes such as nucleus-cytoplasm shuttling,
apoptosis or transcription (Hayashi et al., 2002; Pichler and
Melchior, 2002; Seufert et al., 1995; Wilson and Rangasamy,
2001). This posttranslational reversible process conjugates
SUMO by forming an isopeptide bond between the SUMO C-
terminus glycine residue and a lysine residue within a consensus
motif of the target substrate (Sampson et al., 2001), although non-
consensus motif attachments have also been reported (Wilkinson
and Henley, 2010).
In mammals there are four SUMO paralogues (SUMO1 to
SUMO4). SUMO2 and SUMO3 are almost identical (they differ
from each other by only three N-terminal residues), and are able
to form chains on substrate proteins through internal lysine
residues (Tatham et al., 2001). Contrarily, SUMO1 is attached as
a monomer, or acts as a chain terminator on SUMO2/3 polymers
(Matic et al., 2008; Okura et al., 1996; Tatham et al., 2001).
Finally, SUMO4 isoform has been predicted from genomic data
but has not been identified in vivo yet (Wei et al., 2008).
Briefly, sumoylation starts with an inactive SUMO precursor
that is cleaved at the C-terminus by a SENP (sentrin/SUMO-
specific protease) enzyme. The E1 ligase, consisting of a
heterodimer of SAE1 (SUMO-activating enzyme E1) and
SAE2, activates the SUMO cleaved peptide in an ATP-
dependent manner, and transfers it to the active site of UBC9
(ubiquitin-conjugating 9), the unique E2 ligase. This modified
UBC9 can directly conjugate SUMO to the consensus
sumoylation motif on a target protein, although usually it
interacts with an E3 ligase, which will then recognize the final
substrate. The E3 ligases act as scaffolds bringing together the
SUMO-loaded UBC9 with the target proteins and allowing the
conjugation (Flotho and Melchior, 2013). So far, up to 15
different E3 ligases have been identified in mammal genomes
(Wilkinson and Henley, 2010). SUMO deconjugation is
performed by a family of cysteine proteases, generically named
as SENPs. Six SENP members were first described (Wilkinson
and Henley, 2010) and very recently three new members, DESI1,
DESI2 and USPL1, have been added to the group of SUMO
deconjugating enzymes (Schulz et al., 2012; Shin et al., 2012).
The attachment of SUMO moieties to their substrate targets
regulates many relevant physiological processes by modulating
enzyme activity, activating transcription factors (TFs), shifting
protein subcellular localizations, and eventually, determining
their substrate fate. Therefore, a detailed expression map of the
genes involved in the metabolism of SUMO is fundamental to
understand the cellular role of this small peptide in any tissue.
Several groups have previously studied the expression levels of
some SUMO metabolism enzymes, particularly in neural tissues,
and several E3 ligases related to the regulation of
neurotransmitter receptors have been shown to be expressed in
the retina (Du¨tting et al., 2011). Global transcriptome analysis by
microarray and next generation sequencing have been also
reported for the developing mouse retina, mainly focused on
the expression differences in comparison with mutant defective
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strains (Blackshaw et al., 2004; Brooks et al., 2011). However, no
exhaustive and comprehensive analysis has been reported for the
SUMO pathway genes in the retina to date. On the other hand,
several regulatory circadian rhythm genes, as well as transcription
factors (TFs) relevant for cone and rod differentiation, such as
NR2E3 and NRL, are regulated by sumoylation (Onishi et al.,
2009; Roger et al., 2010; Wright et al., 2004), indicating that the
SUMO pathway is important in retinal physiological function.
Other examples of the SUMO regulatory roles in vision are
illustrated by the fact that mutations in the dual Ubiquitin/SUMO
E3 ligase TOPORS gene cause retinitis pigmentosa in human
(Chakarova et al., 2007) (RetNet, http://www.sph.uth.tmc.edu/
RetNet/); and the SUMO ligases HDAC4 and TLS have been also
involved in photoreceptor survival or apoptosis (Chen and Cepko,
2009; Chen et al., 2011). These cases are probably the tip of the
iceberg concerning the function of SUMO in retina.
In this context, we aimed to analyze the mRNA levels and spatial
expression pattern of the complete list of SUMO and SUMO
pathway enzymes in the mouse retina, as a means to provide an
expression atlas, a reference framework for researchers working in
retinal diseases and/or SUMO enzymes. This expression map will
give useful clues on the function of SUMO during retinal
development and physiology, retinal response to light and
oxidative stress and the regulation of the retinal circadian clock
genes as well as pinpoint new candidate genes for visual disorders.
MATERIALS AND METHODS
Ethics statement
All procedures in mice were performed according to the ARVO statement
for the use of animals in ophthalmic and vision research, as well as the
regulations of the Animal Care facilities (Estabulari de la Facultat de
Farma`cia) at the Universitat de Barcelona (UB). All procedures were
evaluated and approved by the Animal Research Ethics Committee
(Comite´ E`tic d’Experimentacio´ Animal, CEEA) of the UB (Permit
numbers from the Generalitat de Catalunya DAAM 6562 and 7185).
Animal handling, tissue dissection and preparation of samples
Murine retina samples were obtained from P60 C57BL/6J animals.
Animals were euthanized by cervical dislocation (with all efforts made to
minimize animal suffering) at four different time points and light
conditions (as specified in Fig. 1) and retinas were dissected and
immediately frozen. Housing under 12:12 h light/dark cycle (LD) is
usually considered normal conditions. For conditions 1 and 4, animals
were kept in the dark and their retinas were collected in a dark chamber
with dim red light, as mice lack the opsins capable to detect this
wavelength (L-cones). For in situ hybridization, retinas were obtained
from animals reared under normal LD cycle and after 6 h of exposition to
light (condition 3 of Fig. 1A), collected and treated as described
elsewhere (Garanto et al., 2012).
RNA extraction and cDNA generation
For each of the four conditions, three independent samples were analyzed,
and each sample contained three frozen retinas (of two different animals).
Thus, per condition, nine retinas were analyzed in a total of three different
samples. The retinas were homogenized using a Polytron PT1200E
homogenizer (Kinematica, AG, Lucerne, Switzerland). For total RNA
extraction, the High Pure RNA Tissue Kit (Roche Diagnostics,
Indianapolis, IN) was used, following the manufacturer’s instructions
with minor modifications (longer treatment with DNAseI). Reverse
transcription reactions were carried out using the qScriptTM cDNA
Synthesis Kit (Quanta BioSciences, Inc., Gaithersburg, MD).
qRT-PCR
Quantitative reverse transcription PCR was performed using the
LightCyclerH 480 SYBR Green I Master and a LightCyclerH 480
Multiwell Plate 384 (Roche Applied Science) in a final reaction volume
of 10 ml. Raw data were analyzed with the LightCyclerH 480 software
using the Advanced Relative Quantification method. Gapdh expression
was used to normalize the levels of expression. Rho and Cerkl were
considered as reference genes with high and low levels of expression in
the mouse retina, respectively. Given that RT-PCR is a very sensitive
technique, three technical replicates of the same sample were performed
for each gene to minimize procedure errors. The specific gene primers
used are listed in supplementary material Table S1. The error bars
correspond to the s.d. of the expression levels detected in the three
biological samples, depicted in Fig. 1B,C. After testing for equal s.d. and
normal distribution in the different conditions (Bartlett and Shapiro Wilk
tests, respectively), a multiple comparison analysis of the means in the
different conditions was performed using a Tukey-Kramer test to assess
statistical significance.
In situ hybridization
For in situ hybridization, cDNA fragments (400–500 bp) of each gene
were subcloned into pGEM-TH Easy Vector (Promega), and sense/
antisense riboprobes were generated from the flanking T7 or SP6
RNApol promoters. Eighteen micrometre sections were recovered on
either custom made poly-lysine covered slides, or commercial Superfrost
Plus glass slides (Electron Microscopy Sciences, Hatfield, PA), dried 1 h
at RT, rinsed three times for 10 min with phosphate-buffered saline
(PBS), treated with 2 mg/ml proteinase K for 15 min at 37 C˚, washed
twice for 5 min with PBS, and postfixed with 4% PFA. Acetylation with
0.1 M triethanolamine-HCl (pH 8.0) containing first 0.25%, and then
0.5% acetic anhydride, was performed for 5 min each. Hybridization was
carried out overnight at 55 C˚ with digoxigenin-labeled riboprobes (2 mg/
ml ) in 50% formamide, 16Denhardt’s solution, 10% dextran-sulfate, 0.9
M NaCl, 100 mM Tris-HCl (pH 8.0), 5 mM EDTA (pH 8.0), 10 mM
NaH2PO4, and 1 mg/ml yeast tRNA.
After hybridization, slides were washed in 26SSC for 20 min at 55 C˚,
equilibrated in NTE (0.5 M NaCl, 10 mM Tris-HCl pH 8.0, 5 mM
EDTA) at 37 C˚, and then treated with 10 mg/ml RNase A in NTE at 37 C˚
for 30 min. Subsequently, sections were washed at 37 C˚ in NTE for
15 min, twice in 26SSC and 0.26SSC for 15 min each, equilibrated in
Buffer 1 (100 mM Tris-HCl pH 7.5, 150 mM NaCl), and blocked in
Blocking Buffer (1% BSA and 0.1% Triton X-100 in buffer 1) for 1 h.
An anti-digoxigenin-AP conjugate antibody (1:1000; Roche Diagnostics,
Indianapolis, IN) in Blocking Buffer was incubated overnight at 4 C˚.
Sections were then washed twice in Buffer 1 for 15 min, Buffer 2
(100 mM Tris-HCl pH 9.5, 150 mM NaCl), and Buffer 2 supplemented
with 50 mM MgCl2 for 5 min each, prior to exposure to BM Purple AP
Substrate (Roche Diagnostics, Indianapolis, IN). Reactions were stopped
by washing in 16 PBS. Sections were cover-slipped with Fluoprep
(Biome´rieux, France) and photographed using a Leica DFC Camera
connected to a Leica DM IL optic microscope (Leica Microsystems,
Germany).
Retinal explants
Freshly enucleated eyes from mice were manipulated in Leibovitz L15
media, and the retinas were dissected from the pigmented epithelium and
other ocular structures. Careful cuts at the edges were performed to
flatten the tissue and each retina was separately placed with the
photoreceptors upside in a 6 well plate with Neurobasal media (plus 1%
penicillin/streptomycin, 2% L-glutamine, 7.46% glucose, 16.66%
NaH2CO3, 2% B27) on top of a 0.4 mm transwell membrane (30 mm
Diameter, MillicellHCell Culture Inserts). All retinas were kept overnight
at 37 C˚ and 5% CO2 in the dark. One retina from each individual (n56)
was exposed to light for 1.5 h while the other remained in the dark
(conditions 2 and 1, respectively). After the treatment, all retina explants
were individually frozen in liquid nitrogen.
Protein lysates and immunodetection by western blot
Each retinal explant was separately homogenized in RIPA buffer
(Desoxycolate 0.25% w/v, NP40 1% v/v, Tris pH 7.5 1 M, EDTA
500 mM, NaCl 5 M and protease inhibitor). Protein lysates were loaded
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on 10–12.5% SDS-PAGE gels, transferred onto PVDF membranes and
blocked with 5% BSA in PBST for 1 h. Primary antibodies (1:500
dilution) against TLS (Biorbyt, Cambridge, UK), CRX (Abnova, Taiwan)
and NR2E3 (Abcam, Cambridge, UK) were incubated overnight at 4 C˚,
and then with secondary antibodies (dilution 1:2000) for 1 h. For
normalization and quantification, immunodetection (dilution 1:1000)
against either GAPDH (Abcam, Cambridge, UK) or a-Tubulin (Sigma-
Aldrich, St. Louis, MO) were used. The ImageJ software (http://imagej.
nih.gov/ij/) was used for quantification of the bands, followed by
statistical analysis according to a Student’s t-test applied after testing for
equal s.d. and normal distribution (Bartlett and Shapiro-Wilk tests,
respectively).
Fig. 1. Quantitative relative expression of genes encoding SUMO substrates, SUMO metabolism and other retinal enzymes in the mouse retina.
(A) Scheme showing the four conditions of light/dark cycle (grey versus light blocks, respectively) plus the timing of the retinas dissection, which is indicated by
an arrowhead: condition 1 (dark grey) – last dark phase lengthened by 3 h (retinas obtained in the dark); condition 2 (light grey) – last dark phase lengthened by
1.5 h plus 1.5 h of exposition to light (retinas obtained under light); condition 3 (white) – retinas obtained in normal light/dark cycle after 6 h of exposition to
light; condition 4 (black) – retinas obtained in normal light/dark cycle after 2 h of exposition to dark. (B) Transcriptional levels of SUMO substrate and SUMO
metabolism enzyme genes. Levels are obtained as a ratio with Gapdh expression (used for normalization) per 104. (C) Transcriptional levels of some relevant
retinal genes. Rhodopsin levels (right panel) are as high as Gapdh, and the ratio is directly represented, whereas the ratio of transcription factors (left
panel) is multiplied per 104, as in B. All bars in B and C are coloured indicating the condition under which the retinas were obtained (as explained in A). Three
independent retinal cDNA samples (each sample containing 3 different retinas) were analyzed for each of the four conditions. Thus, per each condition 9 retinas
from at least 5 different animals and divided in three different samples, were used. Gene expression values are the average of these three samples per
condition, and the s.d. bars indicated the variability of expression in the different individuals. The Tukey-Kramer test was used for the multiple comparisons of the
condition means. Asterisks (*, ** or ***) show a statistical significant variation (p,0.05, p,0.01 or p,0.001, respectively). The units of expression are directly
comparable among genes, except for Rho.
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RESULTS
Expression levels of SUMO and SUMO pathway enzymes in
the mouse retina
Given that mouse is one of the animal models of choice to study
the retina, and that the human SUMO pathway genes have
orthologues in mouse, we aimed to assess the relative mRNA
expression levels of all known SUMO metabolism enzymes and
provide a preliminary map of their expression pattern in the adult
murine retina. Considering that the SUMO pathway is relevant
for the regulation of the circadian rhythm, we also addressed
whether exposure to light or to darkness caused a transcriptional
effect (induction or repression) in the genes of this pathway. We
analyzed three independent retinal samples per condition and
each sample contained three retinas from different P60 mice
reared in 12:12 h LD. In total, per each condition we used 9
retinas from at least 5 different animals, divided in three different
samples. The four conditions considered were (Fig. 1A) namely:
condition 1 – after 15 h of dark phase (in normal conditions the
animals would already have been exposed to daylight for 3 h);
condition 2 – after 13.5 h of dark phase followed by 1.5 h of light
(to detect quick transcriptional activation/inhibition peaks due to
light exposition and compare directly with the previous case);
condition 3 – in normal daylight phase (after 6 h of daylight), and
finally, condition 4 – in normal dark phase (after 2 h of darkness,
to detect transcriptional activation/inhibition due to darkness
exposure or darkness circadian phase). In order to distinguish
differences in gene expression due to direct light exposition from
those generated by circadian rhythmicity, we compared retinas
obtained at the same time of the day, after 1.5 h of light
exposition (condition 2) compared to the retinas obtained in
sibling mice kept during all this time in the dark after the night
cycle (condition 1). In these circumstances, any gene whose
expression appears modified in the light versus the dark
(condition 2 compared to 1) might reflect the effect of light
exposition irrespective of the circadian rhythm (which will be the
same for the retinas in these two conditions). Conditions 3 and 4
were considered as normal light/dark cycle time-points to
illustrate transcriptional values under circadian rhythmicity.
Quantitative RT-PCRs were performed to assess the expression
levels for the analysis of 30 genes (the designed primer pairs are
listed in supplementary material Table 1), including the reported
SUMO E1, E2, E3 ligases and proteases, plus the SUMO
substrates (Fig. 1B). Moreover, we also analyzed a highly
expressed retinal gene that has been reported to show circadian
rhythmicity (Rho) (von Schantz et al., 1999), plus three
transcription factors that are relevant for cone-rod fate and
function and might be sensitive to light/dark conditions (Fig. 1C).
Two relevant genes involved in retinal dystrophies, the previously
mentioned Rho and Cerkl, were also included as internal
reference threshold values for high and low levels of gene
expression in the retina, respectively.
All the values were normalized with respect to the expression
of Gapdh and multiplied per 104 (except for Rho, which is
expressed four to five orders of magnitude higher), and thus, the
relative values of expression can be directly compared. Fig. 1
shows the mean value and the s.d. of three different biological
samples per gene and condition, where each sample contained at
least 3 retinas. Per gene and sample, every value was obtained by
triplicate (average of three technical replicates) to increase data
robustness.
The three genes encoding the SUMO1, SUMO2 and SUMO3
substrates were highly expressed. Notably, the gene for the only
E2 enzyme (Ubc9) was more highly expressed than the genes
coding for the two components of the E1 ligase heterodimer
(Sae1 and Sae2). Taken together, the group of E3 ligases and
SUMO proteases showed a higher variability in the levels of
expression. The most highly expressed E3 ligase gene was Tls, in
contrast to the basal expression of Egr2 (around two orders of
magnitude lower). Among the deconjugating enzymes, Desi1 was
the most highly expressed, whereas Senp1 and Senp5 showed low
levels of expression. Concerning the analysis of relevant retinal
genes, Rho was the most highly expressed, directly comparable to
Gapdh, followed by Nrl and finally Nr2e3 and Crx.
Although most of the gene transcription levels remained
unaltered in the different light/dark conditions, a few of them
were consistently and significantly altered. As shown in Fig. 2,
Sae1, Senp2 and Rho (pattern I) showed a quick activation peak
when exposed to light (condition 1 versus 2) sustained during the
light and early dark phase (conditions 3 and 4). Similarly, Cbx4
and Desi1 (pattern II) had a constant increase of expression from
condition 1 to 4. The retinal transcription factor Nr2e3 (pattern
III) showed a sharp peak in response to light exposition
(condition 2) that steadily decreased to the initial levels
(condition 4 and 1). Finally, the expression of Sumo2 (pattern
IV) increased during daylight (third condition) and was slightly
lower in the rest of conditions. Although some other behaviour
patterns could be observed, the expression values were too
variable to be statistically significant (e.g. Crx showed a lower
transcript level in condition 1 for some samples compared to the
rest of conditions, suggesting transcriptional activation when
exposed to light).
Spatial expression pattern of the SUMO pathway genes
In order to localize the expression of SUMO substrates and
enzymes in the mouse retina, we resorted to in situ hybridization
as a means to obtain a comprehensive atlas of expression
irrespective of the availability of specific and sensitive
commercial antibodies for all the set of proteins. Antisense
riboprobes (with their corresponding sense riboprobes) were
generated for each gene and hybridized on adult (P60) retinal
sections obtained during light time (condition 3 of Fig. 1A).
Rhodopsin, a highly expressed gene in the inner segment (IN) of
rod photoreceptors, was used as a positive control. For each gene,
the ISH of antisense and sense (negative control) riboprobes were
processed in parallel so that the signal obtained was considered
Fig. 2. Classification of the SUMO-pathway and other retinal genes
according to their pattern of expression activation/inhibition in mouse
under several light-dark conditions. Some SUMO metabolism and other
relevant retinal genes were grouped with statistical significance by the
similarity in their patterns of expression, according to the qRT-PCR. Note that
the first three patterns show an activation by light exposition (condition 1
versus 2) that is further increased (I), maintained (II) or decreased (III) in the
following conditions (3 and 4), while pattern IV showed an isolated increase
in the third condition. Histogram colouring is as in Fig. 1.
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specific for the mRNA localization of every assayed gene, and
the relative intensity of the mRNA detection within the same
retina for each gene is comparable. Representative in situ
hybridization images for all the genes are shown in Fig. 3. In
addition, a qualitative schematic summary of the mRNA
localization data per layer and gene, grouped by expression
pattern, is shown in Fig. 4.
The expression of Sumo1, Sumo2 and Sumo3 was rather
ubiquitous, although some differences could be observed. Sumo1
was highly expressed in the photoreceptors inner segment and in
the plexiform layers, and not detected in the GCL, where Sumo2
showed a high signal; while Sumo3 expression was not detected
in the nuclear layers. Consistent with their instrumental function
in the SUMO pathway, the E1 ligase genes, Sae1 and Sae2, and
the unique E2 Ubc9 shared a similar ubiquitous pattern, although
Ubc9 showed a stronger signal in the GCL.
Not unexpectedly, the proteases and E3 ligases showed a wide
variety of expression patterns (Figs 3 and 4). The inner segment
of photoreceptors showed expression signal for all genes. The
signal is particularly high for Cbx4, Desi2, Mul1, Pias1, Pias4,
Rasd2, Senp1 Senp7, Tls and Uspl1. Notably, both outer and inner
nuclear layers showed a very similar pattern of hybridization, and
perinuclear signal was observed for most genes. Pias1, Senp6 and
Senp7 produced a stronger signal in both ONL and INL, whereas
Tls only did in the INL. On the contrary, Pias2 and RanBP2
produce nearly undetectable signal in both nuclear layers.
Remarkably, high mRNA localization signal for most genes
was observed in the two plexiform layers, particularly in the outer
plexiform layer, in clear contrast with the corresponding sense
riboprobes (negative controls). Of note, the GCL rendered a very
distinctive pattern of mRNA hybridization, in clear contrast to
that observed in the photoreceptor inner segment. The GCL
showed high expression of Cbx4, Hdac4, Pias3, Senp2, Senp6,
Tls and Topors, whereas no – or weak – signal was observed for
Mms21, Pias2, Pias4, RanBP2, Rasd2 and Senp3.
Considering the pattern produced per genes (Fig. 4), Pias2 and
RanBP2 mRNA localization was extremely weak in the retina
layers with a significant number of nuclei (ONL, INL, GCL). Tls
mRNA followed a unique pattern and was strongly expressed and
localized in the photoreceptors (inner segment), the INL and GCL
(Figs 3 and 4). Finally, it might be relevant to note that Senp2
mRNA was localized nuclearly/perinuclearly in some cells at the
GCL, a localization that was not observed for any other SUMO-
pathway gene mRNA (see black arrows in amplified section in
Fig. 3). We selected several genes to perform in situ
hybridizations in mouse retinas obtained in conditions 1 (dark)
and 2 (exposure to light) to compare them with those obtained in
condition 3 (light). No detectable changes in the mRNA
localization in the retinal cell layers were apparent for the
tested genes (data not shown).
Differential gene expression induced by light exposition
To further investigate the possible effect of light induction in
gene expression, retinal explants from several individuals were
performed, in which after the night cycle one of the retinas
remained in the dark (condition 1) while the other was exposed to
light for 1.5 h (condition 2). The lysates from the two retinas per
animal were electrophoresed and immunodetected simultaneously
for direct comparison. The protein levels of TLS (the most highly
expressed gene of the SUMO pathway) as well as the
transcription factors CRX and NR2E3, which showed a
transcriptional activation after light exposition by qRT-PCR,
were analyzed (Fig. 5A). Note that these three proteins produce at
least one weak mirror band of higher molecular weight size when
immunodetected by Western blot, compatible with post-
translational modifications, such as sumoylation (arrowheads in
Fig. 5A). In fact, sumoylation of NR2E3 has already been
reported (Onishi et al., 2009).
According to our results in retinal explants (n56 animals), the
protein levels of CRX and NR2E3 were different in the dark and
light conditions. Remarkably, CRX levels were 1.5 fold higher in
the light and NR2E3, 1.8 fold (statistical significance of p,0.05
and p,0.01 respectively). TLS instead showed a high variability
in the protein expression levels, but no statistically significant
differences were found comparing the explants in the two
conditions (Fig. 5B). The fold values obtained from comparing
the protein levels in the explants of light and dark per animal
were also consistent with these results (Fig. 5C), pointing to light
induction.
DISCUSSION
Most work on the functional relevance of SUMO has focused on
cell cycle, DNA repair and cancer in cultured cells, and data on
the inter-dependence of separate components of the SUMO
pathway in highly specialized tissues are largely absent.
Therefore, reports on the relevance of SUMO in retina are
scanty and most of the published findings relate to sumoylation of
particular substrates, such as TFs, neurotransmitter receptors or
circadian clock regulators. Thus, a systematic descriptive analysis
of the SUMO metabolism gene expression in the retina was
missing. The present work aims to fill this void, and by reporting
mRNA expression profiles and localization in the different adult
mouse retinal layers – under four different conditions at several
times of the light/dark cycle – provide a useful picture in which to
locate the modifier of a protein of interest concerning the
complex circuitry of the vision process.
The qRT-PCR detected the expression of all the SUMO
substrates and enzymes in the mouse retina. As expected, the
genes encoding the substrates, SUMO1 to 3, showed high
expression levels due to their central role in sumoylation. The
genes coding for the two E1 ligases, Sae1 and Sae2, known to act
as a heterodimer, were comparably expressed; and Ubc9,
encoding the unique E2 conjugating enzyme, showed one of the
highest levels of expression among the analyzed genes. The wide
expression range for SUMO E3 ligases and proteases suggest
different retinal roles/relevance, as these enzymes display target
specificity and in most cases, non-redundancy. The least and the
highest expressed SUMO pathway genes were among the E3
ligases: Egr2 (also known as the transcription factor Krox20) and
Tls, respectively (approximately 3 orders of magnitude difference
in mRNA expression levels, arbitrary units, Fig. 1B). In this
context, it is worth noting that Tls (one of the genes causing
amyotrophic lateral sclerosis in human) had been already the
focus of previous works in the retina, given that its
overexpression led to progressive photoreceptor degeneration in
Drosophila (Chen et al., 2011), and that TLS is involved in the
regulation of the receptor of the NMDA neurotransmitter in rat
ganglion retinal cells (Selamat et al., 2009). Other genes
previously reported to play relevant roles in this tissue showed
comparable medium-low level of expression: Hdca4, a promoter
of retinal cells survival (Chen and Cepko, 2009); Topors, a
causative gene of retinitis pigmentosa in humans (Chakarova
et al., 2007), and Pias3, encoding the SUMO E3 ligase that
regulates the repressor function of NR2E3 in mouse cone genes
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Fig. 3. See next page for legend.
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(Onishi et al., 2009). Finally, the SUMO proteases were more
homogeneously expressed, with differences in expression not
larger than one order of magnitude. Notably, the more highly
expressed proteases corresponded to two newly incorporated
genes, Desi1 and Desi2 (Shin et al., 2012), indicating that their
function might be important in the retina.
Focusing on the three TFs relevant for photoreceptor fate, their
levels of expression were higher than the genes of the SUMO
pathway, probably due to their central role in regulating genes for
photoreceptor function and maintenance. Crx and Nr2e3 showed
similar levels of expression, whereas Nrl (one of the genes
controlling rod fate) was the most highly expressed (around ten
folds the expression of Crx), consistent with the high number of
rods in the murine retina.
Gene expression in the mouse retina had been previously
profiled either during embryonic and postnatal retinal
development using serial analysis of gene expression (SAGE)
and microarrays (Blackshaw et al., 2004), or comparing the
retinal transcriptome of wild-type and Nrl2/2 mice by next
generation sequencing (NGS) (Brooks et al., 2011). These reports
focused on the identification of upregulated or downregulated
genes during these processes or genetic conditions and, except for
Pias1 and Pias3 during retinal development, no SUMO pathway
gene showed any major difference in its expression. These
apparent stasis may be explained by maintenance of the
transcription levels during retinal development for most of the
SUMO pathway enzymes, or probably, that subtle differences
(less than two fold, for instance) might be missed in high-
throughput analysis due to very stringent cut-off values, and
might stand out in smaller scale and more targeted transcriptional
studies, such as the work presented here. Indeed, the regulation of
SUMO genes function might also rely on mechanisms other than
transcription, such as protein stability or activity regulation by
post-translational modifications (e.g. many SUMO pathway
enzymes show retroactive and crosstalk regulation by SUMO
and ubiquitin (Denuc and Marfany, 2010)).
When focusing on the expression in the four different light/
dark conditions, SUMO machinery seemed to remain mainly
unaltered. Only Sumo2, Sae1, Cbx4, Desi1 and Senp2 showed
statistical significant differences in the expression levels in some
of the four conditions. SAE1 is known to act as a heterodimer
together with SAE2, and the induction of Sae1 observed after
light exposition might reflect a different regulation for these two
genes. In the entire set of ligase genes only Cbx4 showed
significant variations, with maximum level of transcription at
Fig. 3. In situ hybridization on murine retina cryosections of the genes
encoding SUMO substrates and SUMO E1, E2, and E3 ligases, and
proteases. Representative images obtained after the in situ hybridization of
Antisense (AS) and Sense (S) digoxigenin-labelled riboprobes, stained for
the same period of time per each gene. Antisense riboprobes reflect the
pattern of gene expression, whereas the sense probes are the corresponding
negative controls. The antisense Rhodopsin probe, which strongly labels the
inner photoreceptor segment, was used as a positive control for the
assay. RPE, Retinal Pigment epithelium; PhR, Photoreceptor cell layer; ONL,
outer nuclear layer; OPL, Outer plexiform layer; INL, Inner nuclear layer, IPL,
inner plexiform layer; GCL, ganglion cell layer. The boxed region at the
bottom right is an amplification of the Senp2 in situ hybridization at the GCL
level. The black arrowheads indicate nuclear/perinuclear mRNA localization.
Fig. 4. Summarized graphic representation of the
mRNA pattern of the SUMO pathway genes as
revealed by in situ hybridization on murine retina
cryosections. Colour intensity in this figure reflects in
situ hybridization signal intensity per each gene by direct
comparison of the signal rendered in different layers in
the same retinal preparation. Intensities are not directly
comparable among different genes, as each in situ
hybridization required different incubation times. For
each gene, sense (negative control) and antisense
riboprobes were always processed in parallel and
following the same incubation times. This graphic
interpretation depicts the mRNA positive signal per gene
and layer after deducting the corresponding negative
signal (if any). Phr, Photoreceptor cell layer; ONL, outer
nuclear layer; OPL, Outer plexiform layer; INL, Inner
nuclear layer, IPL, inner plexiform layer; GCL, ganglion
cell layer.
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night (condition 4), while in the protease group, formed by fewer
genes, Desi1 and Senp2 were the only ones to show differential
expression levels in light versus dark conditions. In summary,
four different patterns of expression emerged. One possible
explanation for these results would be that sumoylation as a
posttranslational modification could be regulating (or regulated
by) the response to light exposition.
As the analyzed TFs are direct transcriptional regulators of
downstream target genes, the differences in expression due to
light exposition might be relevant. A small increase or decrease in
their mRNA and protein levels, even their interaction in
activating or inhibiting complexes might cause a significant
cascade effect for the physiology of the retina. In this context, it is
worth noting that the increase in mRNA levels after light
exposition has been confirmed for Crx and Nr2e3 by their protein
relative levels in retinal explants. The differences in transcription
were amplified in both cases at the protein level (for instance
Nr2e3 transcript levels were increased 1.4 fold when comparing
condition 2 (light) to 1 (dark), while the protein levels were 1.8
fold higher). On the other hand, no apparent difference in the
sumoylation state of the protein NR2E3 could be observed
between these two conditions. Further work may reveal the
relevance of this increase of expression when the retinas are
exposed to light. Finally, Rho (whose expression is regulated by
the above transcription factors) follows circadian rhythmicity and
has been reported to show a sharp transcriptional peak at the
starting time of the dark phase (von Schantz et al., 1999).
Conditions 3 and 4 in this work overlapped this exact timing and
did not exactly coincide with this sharp transcriptional induction.
We cannot discard that a similar sharp transcriptional response
during daily light/dark cycling went undetected by our analysis in
any of the studied genes.
Concerning mRNA localization, in situ hybridization is not a
direct quantitative assay, nonetheless several signal intensities
(high, low and non-detectable signal) were visible for each gene
in the retinal layers (Fig. 4). Most genes showed a ubiquitous
signal, including plexiform and nuclear layers, pointing to a basal
function in most cells. Notably, all the analyzed genes were
expressed in photoreceptors, and the mRNA mainly localized in
the inner segment, where most of the translational machinery
resides. More remarkable was the detection of high levels of
mRNA expression in the plexiform layers, pointing to localization
in the synaptic processes and buds (the low resolution of in situ
hybridization did not allow a more accurate assignment). Although
these results should be with some caution until further work refine
this localization and its physiological relevance, there are
increasing evidences of specific mRNA localization along the
axons and in the synapses, forming ribonucleoprotein complexes
(RNPs, P-bodies, stress granules, etc.) (Liu-Yesucevitz et al.,
2011). The E3 ligase Pias3 is one of the few SUMO pathway genes
previously studied in the retina, and previous reports detected high
Pias3 mRNA expression in developing photoreceptors whereas the
signal seemed to decrease in the adult retina (Blackshaw et al.,
2004). On the other hand, other reports detected the PIAS3 protein
in the GCL and in the photoreceptor outer segment in the mature
retina (Du¨tting et al., 2011), in accordance to its role as a NR2E3
regulator. In this work, we also detected Pias3 mRNA in the adult
retina (P60) throughout all retinal layers but more strongly at the
GCL (Figs 3 and 4).
In summary, the wide expression of the SUMO pathway genes
and the diversity of detected expression patterns in the different
retinal cell layers and light/dark conditions in mouse – added to
other previous reports on particular genes and targets – clearly
supports sumoylation as a relevant post-translational modification
in this tissue. Since one of the emerging concepts is the
requirement for simultaneous SUMO conjugation/deconjugation
of multiple protein targets involved in the same biological
process, within dynamic post-translational complexes (Flotho and
Melchior, 2013; Psakhye and Jentsch, 2012), this mRNA
expression atlas intends to be a reference framework for retinal
Fig. 5. Immunodetection of several proteins in retinal explants under dark or light conditions. (A) Western blots of TLS, CRX, and NR2E3 in retinal
explants of single individuals in which one retina was maintained in the dark (D, condition 1), while the other counterpart was exposed to light for 90 min after
dark (L, condition 2). This is a representative image of n56. Immunodetection of GAPDH or a-tubulin was used as a normalization control. Arrowheads indicate
higher molecular weight bands compatible with post-translational modifications, such as sumoylation. (B) Protein level quantification of the retinal explants
in dark (1) and light (2) conditions (dark and light grey, respectively). Bars indicate s.d. (n56). Fold-induction is in arbitrary units, considering the mean value of
the protein level in the dark as 1. Statistical significance is indicated by * (p,0.05) and ** (p,0.01) according to a Student’s t-test, assuming normality (after
Bartlett and Shapiro-Wilk tests). (C) Fold induction of the protein expression levels between the light vs dark conditions in the retinal explants from the
same animal. For each pair of explants, the expression level in the dark was arbitrarily considered as the unity to allow direct comparison.
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researchers and may contribute to depict a more comprehensive
view of the SUMO-regulated processes in the retina.
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